Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
SUFENTA PRESERVATIVE FREE is a potent synthetic opioid agonist (sufentanil citrate) administered by injection for acute and chronic pain management. It is a Schedule II controlled substance used primarily in perioperative and critical care settings. The preservative-free formulation reduces the risk of adverse reactions from additives in multi-dose vials.
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting team focus is shifting toward lifecycle management and cost containment rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
SUFENTA PRESERVATIVE FREE offers limited career growth opportunities given its approaching loss of exclusivity and zero linked job positions. Roles on this product focus on defending market share and managing the transition to generic competition rather than launching or expanding a growing franchise.
Worked on SUFENTA PRESERVATIVE FREE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.